Opportunity ID: 357815

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-25-326
Funding Opportunity Title: Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 18, 2024
Last Updated Date: Dec 18, 2024
Original Closing Date for Applications: Jan 31, 2028
Current Closing Date for Applications: Jan 31, 2028
Archive Date: Mar 07, 2028
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
For profit organizations other than small businesses
Special district governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Public housing authorities/Indian housing authorities
Independent school districts
Small businesses
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this NOFO is to provide investigators with a mechanism to access contract research/medical organizations (CROs/CMOs) and subject matter experts (SMEs) within the NINDS Ultra-Rare Gene-based Therapy (URGenT) Network to support planning, manufacturing, and limited nonclinical therapeutic development efforts.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-25-326.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 357815 Full Announcement-PAR-25-326 -> PAR-25-326-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-I Use for due dates on or after January 25, 2025 PKG00289740 Jan 09, 2025 Jan 31, 2028 View

Package 1

Mandatory forms

357815 RR_SF424_5_0-5.0.pdf

357815 PHS398_CoverPageSupplement_5_0-5.0.pdf

357815 RR_OtherProjectInfo_1_4-1.4.pdf

357815 RR_KeyPersonExpanded_4_0-4.0.pdf

357815 PHS398_ResearchPlan_5_0-5.0.pdf

357815 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

357815 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T16:12:21-05:00

Share This Post, Choose Your Platform!

About the Author: